e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Lung surgery: preoperative assessment and postoperative outcome
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The utility of vibration response imaging for calculation of ppoFEV1 and ppoD
L,CO
in patients with lung cancer referred for resection – The influence of coexisting COPD
B. Marinov, A. Chapkanov, M. Todorova, G. Paskalev, S. Kostianev (Plovdiv, Bulgaria)
Source:
Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Session:
Lung surgery: preoperative assessment and postoperative outcome
Session type:
Oral Presentation
Number:
196
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Marinov, A. Chapkanov, M. Todorova, G. Paskalev, S. Kostianev (Plovdiv, Bulgaria). The utility of vibration response imaging for calculation of ppoFEV1 and ppoD
L,CO
in patients with lung cancer referred for resection – The influence of coexisting COPD. Eur Respir J 2013; 42: Suppl. 57, 196
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Lung volume reduction effect after lobectomy in COPD patients
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013
Smoking status affects VRI assissted prediction of postoperative FEV1 and D
L,CO
in patients with lung cancer
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014
Lobectomy at patients with lung cancer and a chronic obstructive pulmonary disease as analogue of lung volume reduction surgery in COPD patients: To do or not to do?
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Lung cancer risk based on visual assessment of emphysema and interstitial abnormalities in low dose chest CT
Source: International Congress 2014 – Different modalities and techniques for lung imaging
Year: 2014
Pre-operative peak workload as predictor of post-operative complications in patients undergoing pulmonary resection for lung cancer
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Diaphragm motion and lung function prediction in patients operated for lung cancer – A pilot study on 27 patients
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013
No more bets? FEV1, DLCO or exercise test – What is essential in the qualifying of patients with lung cancer for surgery?
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
The impact of pulmonary rehabilitation on preoperative inflammatory markers in lung cancer patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Age related influence of COPD on postoperative pulmonary morbidity in lung cancer patients
Source: Annual Congress 2013 –Oncological thoracic surgery
Year: 2013
Using exhaled breath profiles in the discrimination between COPD, lung cancer and their co-morbidity
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Lung volume assessment on 3D-CT and estimated postoperative pulmonary function for lung cancer patients with and without COPD
Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery
Year: 2014
Prevalence and risk factors for postoperative pulmonary complications after lung cancer surgery in patients with early stage of COPD
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Evaluation of spirometry test as monitoring tool in lung cancer patients
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Stereotactic body radiation does not impair respiratory health in patients with stage I non-small cell lung cancer
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
Three-year spirometric evolution after lobectomy in lung cancer patients with or without COPD previous surgery
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Physiological predictors of mortality in high-risk patients undergoing surgery for lung cancer
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Lung function in the elderly patients with a diagnosis of lung cancer - A challenge for the surgical treatment?
Source: International Congress 2015 – Surgery and lung cancer: results and complications
Year: 2015
Is there a change in pulmonary function in patients with COPD and primary lung cancer treated with radiofrequency ablation (RFA)?
Source: International Congress 2014 – Advances in diagnosis and therapy of thoracic tumours
Year: 2014
A prospective study of survival after surgery for early stage non-small cell lung cancer in patients with COPD
Source: International Congress 2015 – Risk assessment and prevention of complications in thoracic surgery
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept